LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4650
+0.0150 (3.33%)
At close: Jul 31, 2026
LTR Pharma Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 25.78 | 31.81 | 3.1 | 1.73 | 1.91 | 0.15 |
Cash & Short-Term Investments | 25.78 | 31.81 | 3.1 | 1.73 | 1.91 | 0.15 |
Cash Growth | -18.95% | 925.31% | 79.46% | -9.56% | 1205.48% | - |
Accounts Receivable | 0.01 | 0 | - | - | - | - |
Other Receivables | 0.16 | 0.24 | 0.27 | 0.06 | 0.04 | - |
Receivables | 0.18 | 0.25 | 0.27 | 0.06 | 0.04 | - |
Inventory | 0.02 | 0.02 | - | - | - | - |
Total Current Assets | 26.31 | 32.07 | 3.37 | 1.79 | 1.95 | 0.15 |
Property, Plant & Equipment | 0.01 | 0.01 | 0 | - | - | - |
Long-Term Investments | 1 | 0.12 | - | - | - | - |
Other Long-Term Assets | - | - | - | - | - | 0 |
Total Assets | 27.32 | 32.21 | 3.37 | 2.09 | 2.25 | 0.42 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.12 | 0.11 | 0.24 | 0.01 | 0.47 | 0 |
Accrued Expenses | 0.21 | 0.5 | 0.13 | 0.01 | 0.01 | 0 |
Short-Term Debt | - | - | - | - | - | 0.36 |
Other Current Liabilities | 0.13 | 0.1 | 0.06 | - | - | 0.1 |
Total Current Liabilities | 0.46 | 0.7 | 0.43 | 0.02 | 0.48 | 0.46 |
Total Liabilities | 0.46 | 0.7 | 0.43 | 0.02 | 0.48 | 0.46 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 44.11 | 44.11 | 10.74 | 4.53 | 2.79 | - |
Retained Earnings | -20.83 | -15.07 | -9.48 | -2.52 | -1.07 | -0.04 |
Comprehensive Income & Other | 3.58 | 2.47 | 1.67 | 0.07 | 0.04 | - |
Shareholders' Equity | 26.86 | 31.51 | 2.94 | 2.07 | 1.77 | -0.04 |
Total Liabilities & Equity | 27.32 | 32.21 | 3.37 | 2.09 | 2.25 | 0.42 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | - | - | - | - | - | 0.36 |
Net Cash (Debt) | 25.78 | 31.81 | 3.1 | 1.73 | 1.91 | -0.21 |
Net Cash Growth | -18.95% | 925.31% | 79.46% | -9.56% | - | - |
Net Cash Per Share | 0.14 | 0.19 | 0.02 | 0.01 | - | - |
Filing Date Shares Outstanding | 181.65 | 180.98 | 153.8 | 414.9 | - | - |
Total Common Shares Outstanding | 181.65 | 180.98 | 139.42 | 414.9 | - | - |
Working Capital | 25.85 | 31.37 | 2.94 | 1.77 | 1.48 | -0.32 |
Book Value Per Share | 0.15 | 0.17 | 0.02 | 0.00 | - | - |
Tangible Book Value | 26.86 | 31.51 | 2.94 | 2.07 | 1.77 | -0.04 |
Tangible Book Value Per Share | 0.15 | 0.17 | 0.02 | 0.00 | - | - |